Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma J de Ronde

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|September 25, 2013
Identifying subgroup markers in heterogeneous populationsJorma J de Ronde, Guillem Rigaill, Sven Rottenberg, et al.
Plos One|February 22, 2014
Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypesJorma J de Ronde, Marc Jan Bonder, Esther H Lips, et al.
BMC Research Notes|November 13, 2010
KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH dataJorma J de Ronde, Christiaan Klijn, Arno Velds, et al.
Plos One|February 25, 2011
Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissueLorenza Mittempergher, Jorma J de Ronde, Marja Nieuwland, et al.
Breast Cancer Research and Treatment|August 12, 2009
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseJorma J de Ronde, Juliane Hannemann, Hans Halfwerk, et al.
Breast Cancer Research and Treatment|December 4, 2012
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancerJorma J de Ronde, Esther H Lips, Lennart Mulder, et al.
Breast Cancer Research and Treatment|May 15, 2013
Platform comparisons for identification of breast cancers with a BRCA-like copy number profilePhilip C Schouten, Ewald van Dyk, Linde M Braaf, et al.
Annals of Surgical Oncology|June 21, 2013
Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrationsSjoerd C Bruin, Jorma J de Ronde, Bas Wiering, et al.
Breast Cancer Research and Treatment|September 11, 2012
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancerEsther H Lips, Rita A Mukhtar, Christina Yau, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|September 25, 2013
Identifying subgroup markers in heterogeneous populationsJorma J de Ronde, Guillem Rigaill, Sven Rottenberg, et al.
Plos One|February 22, 2014
Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypesJorma J de Ronde, Marc Jan Bonder, Esther H Lips, et al.
BMC Research Notes|November 13, 2010
KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH dataJorma J de Ronde, Christiaan Klijn, Arno Velds, et al.
Plos One|February 25, 2011
Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissueLorenza Mittempergher, Jorma J de Ronde, Marja Nieuwland, et al.
Breast Cancer Research and Treatment|August 12, 2009
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseJorma J de Ronde, Juliane Hannemann, Hans Halfwerk, et al.
Breast Cancer Research and Treatment|December 4, 2012
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancerJorma J de Ronde, Esther H Lips, Lennart Mulder, et al.
Breast Cancer Research and Treatment|May 15, 2013
Platform comparisons for identification of breast cancers with a BRCA-like copy number profilePhilip C Schouten, Ewald van Dyk, Linde M Braaf, et al.
Annals of Surgical Oncology|June 21, 2013
Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrationsSjoerd C Bruin, Jorma J de Ronde, Bas Wiering, et al.
Breast Cancer Research and Treatment|September 11, 2012
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancerEsther H Lips, Rita A Mukhtar, Christina Yau, et al.
Pageof 1